<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_fasting" title="Effects of Periodic Fasting on Fatty Liver Index — A Prospective Observational Study" shortTitle="fasting" author="Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6643/11/11/2601/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
4.	LS	4.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="frag">
Diet	NN	diet
</s>
<s type="decl">
interventions	NNS	intervention
are	VBP	be
well-established	JJ	well-established
strategies	NNS	strategy
to	TO	to
reduce	VB	reduce
body	NN	body
weight	NN	weight
and	CC	and
improve	VB	improve
glucose	NN	glucose
metabolism	NN	metabolism
,	,	,
however	RB	however
no	DT	no
evidence	NN	evidence
exists	VBZ	exist
about	IN	about
the	DT	the
effects	NNS	effect
of	IN	of
periodic	JJ	periodic
fasting	NN	fasting
on	IN	on
NAFLD	NNP	NAFLD
.	.	.
</s>
<s type="decl">
This	DT	this
study	NN	study
is	VBZ	be
the	DT	the
first	JJ	first
to	TO	to
show	VB	show
the	DT	the
beneficial	JJ	beneficial
effects	NNS	effect
of	IN	of
periodic	JJ	periodic
fasting	NN	fasting
on	IN	on
fatty	JJ	fatty
liver	NN	liver
.	.	.
</s>
<s type="decl">
The	DT	the
results	NNS	result
of	IN	of
our	PRP$	our
study	NN	study
supported	VBD	support
the	DT	the
hypothesis	NN	hypothesis
that	IN	that
FLI	NNP	FLI
,	,	,
a	DT	a
surrogate	JJ	surrogate
parameter	NN	parameter
of	IN	of
fatty	JJ	fatty
liver	NN	liver
,	,	,
significantly	RB	significantly
decreases	VBZ	decrease
in	IN	in
individuals	NNS	individual
with	IN	with
and	CC	and
without	IN	without
T2DM	NNP	T2DM
after	IN	after
a	DT	a
fasting	NN	fasting
intervention	NN	intervention
of	IN	of
at	IN	at
least	JJS	least
6	CD	6
days	NNS	day
.	.	.
</s>
<s type="decl">
The	DT	the
prospective	JJ	prospective
study	NN	study
design	NN	design
according	VBG	accord
to	IN	to
a	DT	a
standardized	VBN	standardize
protocol	NN	protocol
with	IN	with
a	DT	a
well-established	JJ	well-established
fasting	VBG	fast
technique	NN	technique
and	CC	and
a	DT	a
close	JJ	close
clinical	JJ	clinical
monitoring	NN	monitoring
was	VBD	be
a	DT	a
strength	NN	strength
of	IN	of
this	DT	this
study	NN	study
.	.	.
</s>
</p>
<p>
<s type="decl">
Weight	NN	weight
reduction	NN	reduction
and	CC	and
improvement	NN	improvement
of	IN	of
fatty	NN	fatty
liver	NN	liver
indicators	NNS	indicator
are	VBP	be
known	VBN	know
to	TO	to
be	VB	be
interrelated	JJ	interrelated
.	.	.
</s>
<s type="decl">
Our	PRP$	our
results	NNS	result
indicate	VBP	indicate
that	IN	that
even	RB	even
a	DT	a
modest	JJ	modest
reduction	NN	reduction
of	IN	of
BMI	NNP	BMI
improved	VBD	improve
surrogate	JJ	surrogate
markers	NNS	marker
of	IN	of
fatty	JJ	fatty
liver	NN	liver
.	.	.
</s>
<s type="decl">
Indeed	RB	indeed
,	,	,
in	IN	in
nearly	RB	nearly
half	NN	half
of	IN	of
the	DT	the
subjects	NNS	subject
in	IN	in
the	DT	the
highest	JJS	high
risk	NN	risk
category	NN	category
(	-LRB-	(
FLI	NNP	FLI
&gt;	SYM	&gt;
60	CD	60
)	-RRB-	)
,	,	,
a	DT	a
BMI	NN	BMI
reduction	NN	reduction
of	IN	of
less	JJR	less
than	IN	than
5	CD	5
%	NN	%
was	VBD	be
sufficient	JJ	sufficient
to	TO	to
induce	VB	induce
a	DT	a
shift	NN	shift
to	IN	to
a	DT	a
lower	JJR	low
risk	NN	risk
category	NN	category
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
most	JJS	most
patients	NNS	patient
,	,	,
NAFLD	NNP	NAFLD
is	VBZ	be
associated	VBN	associate
with	IN	with
features	NNS	feature
of	IN	of
metabolic	NN	metabolic
syndrome	NN	syndrome
,	,	,
central	JJ	central
obesity	NN	obesity
,	,	,
elevated	VBN	elevate
blood	NN	blood
pressure	NN	pressure
,	,	,
dyslipidemia	NN	dyslipidemia
,	,	,
hyperglycemia	NN	hyperglycemia
,	,	,
and	CC	and
insulin	NN	insulin
resistance	NN	resistance
.	.	.
</s>
<s type="decl">
Although	IN	although
these	DT	this
pathologies	NNS	pathology
can	MD	can
be	VB	be
addressed	VBN	address
by	IN	by
lifestyle	NN	lifestyle
interventions	NNS	intervention
,	,	,
in	IN	in
daily	JJ	daily
life	NN	life
the	DT	the
adherence	NN	adherence
to	IN	to
the	DT	the
necessary	JJ	necessary
lifestyle	NN	lifestyle
changes	NNS	change
is	VBZ	be
poor	JJ	poor
,	,	,
resulting	VBG	result
in	IN	in
suboptimal	JJ	suboptimal
outcomes	NNS	outcome
.	.	.
</s>
<s type="decl">
In	IN	in
contrast	NN	contrast
,	,	,
in	IN	in
pragmatic	JJ	pragmatic
programs	NNS	program
there	EX	there
is	VBZ	be
a	DT	a
greater	JJR	great
benefit	NN	benefit
in	IN	in
a	DT	a
more	RBR	more
substantial	JJ	substantial
weight	NN	weight
loss	NN	loss
,	,	,
particularly	RB	particularly
at	IN	at
early	JJ	early
stages	NNS	stage
of	IN	of
the	DT	the
intervention	NN	intervention
period	NN	period
.	.	.
</s>
<s type="decl">
Hence	RB	hence
,	,	,
periodic	JJ	periodic
fasting	NN	fasting
can	MD	can
significantly	RB	significantly
reduce	VB	reduce
weight	NN	weight
,	,	,
and	CC	and
this	DT	this
effect	NN	effect
can	MD	can
be	VB	be
maintained	VBN	maintain
over	IN	over
time	NN	time
.	.	.
</s>
</p>
<p>
<s type="decl">
There	EX	there
are	VBP	be
several	JJ	several
concerns	NNS	concern
about	IN	about
the	DT	the
adverse	JJ	adverse
effects	NNS	effect
of	IN	of
fasting	VBG	fast
.	.	.
</s>
<s type="decl">
Several	JJ	several
non-fatal	JJ	non-fatal
(	-LRB-	(
e.g.	FW	e.g.
,	,	,
headache	NN	headache
)	-RRB-	)
and	CC	and
rarely	RB	rarely
fatal	JJ	fatal
(	-LRB-	(
e.g.	FW	e.g.
,	,	,
ventricular	JJ	ventricular
arrhythmia	NN	arrhythmia
)	-RRB-	)
events	NNS	event
have	VBP	have
been	VBN	be
reported	VBN	report
.	.	.
</s>
<s type="decl">
In	IN	in
contrast	NN	contrast
,	,	,
no	DT	no
severe	JJ	severe
adverse	JJ	adverse
events	NNS	event
were	VBD	be
found	VBN	find
in	IN	in
a	DT	a
cohort	NN	cohort
of	IN	of
1422	CD	1422
subjects	NNS	subject
treated	VBN	treat
with	IN	with
a	DT	a
periodic	JJ	periodic
fasting	NN	fasting
lasting	VBG	last
4	CD	4
–	SYM	-
21	CD	21
days	NNS	day
,	,	,
.	.	.
</s>
<s type="decl">
Michalsen	NNP	Michalsen
et	FW	et
al.	FW	al.
evaluated	VBD	evaluate
the	DT	the
acceptance	NN	acceptance
,	,	,
safety	NN	safety
,	,	,
effects	NNS	effect
on	IN	on
health-related	JJ	health-related
outcomes	NNS	outcome
,	,	,
and	CC	and
lifestyle	NN	lifestyle
adherence	NN	adherence
of	IN	of
fasting	NN	fasting
therapy	NN	therapy
in	IN	in
different	JJ	different
chronic	JJ	chronic
internal	JJ	internal
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
They	PRP	they
found	VBD	find
no	DT	no
serious	JJ	serious
adverse	JJ	adverse
events	NNS	event
throughout	IN	throughout
their	PRP$	their
study	NN	study
.	.	.
</s>
<s type="decl">
Our	PRP$	our
study	NN	study
supports	VBZ	support
the	DT	the
hypothesis	NN	hypothesis
that	IN	that
fasting	NN	fasting
therapy	NN	therapy
provided	VBN	provide
in	IN	in
a	DT	a
controlled	VBN	control
clinical	JJ	clinical
setting	NN	setting
is	VBZ	be
a	DT	a
safe	JJ	safe
intervention	NN	intervention
.	.	.
</s>
</p>
<p>
<s type="decl">
There	EX	there
is	VBZ	be
a	DT	a
large	JJ	large
body	NN	body
of	IN	of
evidence	NN	evidence
on	IN	on
the	DT	the
beneficial	JJ	beneficial
effects	NNS	effect
of	IN	of
carbohydrate	NN	carbohydrate
restriction	NN	restriction
and	CC	and
hypocaloric	JJ	hypocaloric
diets	NNS	diet
on	IN	on
NAFLD	NNP	NAFLD
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
also	RB	also
been	VBN	be
shown	VBN	show
that-at	IN	that-at
equal	JJ	equal
levels	NNS	level
of	IN	of
weight	NN	weight
reduction-a	NN	reduction-a
carbohydrate-restricted	JJ	carbohydrate-restricted
diet	NN	diet
leads	VBZ	lead
to	IN	to
a	DT	a
significantly	RB	significantly
greater	JJR	great
intrahepatic	JJ	intrahepatic
triglyceride	NN	triglyceride
reduction	NN	reduction
than	IN	than
low-calorie	JJ	low-calorie
diet	NN	diet
alone	RB	alone
.	.	.
</s>
<s type="decl">
The	DT	the
metabolic	JJ	metabolic
advantage	NN	advantage
of	IN	of
carbohydrate	NN	carbohydrate
restriction	NN	restriction
appears	VBZ	appear
to	TO	to
be	VB	be
related	VBN	relate
to	IN	to
a	DT	a
more	RBR	more
pronounced	VBN	pronounce
lipid	NN	lipid
oxidation	NN	oxidation
and	CC	and
enhanced	VBN	enhance
ketogenesis	NN	ketogenesis
.	.	.
</s>
<s type="decl">
In	IN	in
recent	JJ	recent
years	NNS	year
,	,	,
intermittent	JJ	intermittent
and	CC	and
periodic	JJ	periodic
fasting	NN	fasting
has	VBZ	have
gained	VBN	gain
popularity	NN	popularity
as	IN	as
an	DT	a
alternative	NN	alternative
to	IN	to
continuous	JJ	continuous
caloric	JJ	caloric
restriction	NN	restriction
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
to	IN	to
the	DT	the
weight	NN	weight
loss	NN	loss
effects	NNS	effect
,	,	,
periodic	JJ	periodic
fasting	NN	fasting
is	VBZ	be
associated	VBN	associate
with	IN	with
several	JJ	several
metabolic	JJ	metabolic
benefits	NNS	benefit
,	,	,
including	VBG	include
the	DT	the
improvement	NN	improvement
of	IN	of
lipid	NN	lipid
profiles	NNS	profile
.	.	.
</s>
<s type="decl">
This	DT	this
has	VBZ	have
been	VBN	be
also	RB	also
shown	VBN	show
for	IN	for
intermittent	JJ	intermittent
fasting	NN	fasting
,	,	,
e.g.	FW	e.g.
,	,	,
Ramadan	NNP	Ramadan
fasting	VBG	fast
.	.	.
</s>
<s type="decl">
The	DT	the
key	JJ	key
mechanism	NN	mechanism
responsible	JJ	responsible
for	IN	for
many	JJ	many
of	IN	of
these	DT	this
beneficial	JJ	beneficial
effects	NNS	effect
is	VBZ	be
the	DT	the
metabolic	JJ	metabolic
switch	NN	switch
from	IN	from
the	DT	the
utilization	NN	utilization
of	IN	of
glycogenolysis-derived	JJ	glycogenolysis-derived
glucose	NN	glucose
to	IN	to
fatty	NN	fatty
acids	NNS	acid
and	CC	and
fatty	JJ	fatty
acid-derived	JJ	acid-derived
ketones	NNS	ketone
,	,	,
i.e.	FW	i.e.
,	,	,
a	DT	a
fundamental	JJ	fundamental
switch	NN	switch
from	IN	from
lipid	NN	lipid
synthesis	NN	synthesis
and	CC	and
fat	JJ	fat
storage	NN	storage
to	IN	to
mobilization	NN	mobilization
of	IN	of
fat	NN	fat
in	IN	in
the	DT	the
form	NN	form
of	IN	of
free	JJ	free
fatty	NN	fatty
acids	NNS	acid
and	CC	and
fatty	JJ	fatty
acid-derived	JJ	acid-derived
ketones	NNS	ketone
.	.	.
</s>
<s type="decl">
This	DT	this
occurs	VBZ	occur
between	IN	between
12	CD	12
and	CC	and
36	CD	36
hours	NNS	hour
after	IN	after
cessation	NN	cessation
of	IN	of
food	NN	food
consumption	NN	consumption
.	.	.
</s>
<s type="decl">
Hyperinsulinemia	NN	hyperinsulinemia
suppresses	VBZ	suppress
ketogenesis	NN	ketogenesis
and	CC	and
therefore	RB	therefore
prolongs	VBZ	prolong
the	DT	the
time	NN	time
to	TO	to
switch	VB	switch
in	IN	in
cases	NNS	case
of	IN	of
obesity	NN	obesity
,	,	,
insulin	NN	insulin
resistance	NN	resistance
,	,	,
and	CC	and
T2DM	NN	T2DM
.	.	.
</s>
<s type="decl">
Although	IN	although
there	EX	there
is	VBZ	be
some	DT	some
evidence	NN	evidence
of	IN	of
impaired	VBN	impair
ketogenesis	NN	ketogenesis
during	IN	during
the	DT	the
progression	NN	progression
of	IN	of
liver	NN	liver
disease	NN	disease
to	IN	to
steatohepatitis	NN	steatohepatitis
,	,	,
therapies	NNS	therapy
that	WDT	that
increase	VBP	increase
hepatic	JJ	hepatic
ketogenesis	NN	ketogenesis
are	VBP	be
expected	VBN	expect
nonetheless	RB	nonetheless
to	TO	to
ameliorate	VB	ameliorate
NAFLD	NNP	NAFLD
.	.	.
</s>
</p>
<p>
<s type="decl">
Our	PRP$	our
data	NNS	datum
provided	VBD	provide
first	JJ	first
evidence	NN	evidence
that	IN	that
periodic	JJ	periodic
fasting	NN	fasting
leads	VBZ	lead
to	IN	to
a	DT	a
clearance	NN	clearance
of	IN	of
liver	NN	liver
fat	NN	fat
:	:	:
fasting	NN	fasting
significantly	RB	significantly
reduced	VBD	reduce
FLI	NNP	FLI
and	CC	and
increased	VBD	increase
the	DT	the
proportion	NN	proportion
of	IN	of
patients	NNS	patient
without	IN	without
NAFLD	NNP	NAFLD
(	-LRB-	(
FLI	NNP	FLI
&lt;	SYM	&lt;
30	CD	30
units	NNS	unit
;	:	;
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
2	CD	2
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
effects	NNS	effect
of	IN	of
fasting	NN	fasting
therapy	NN	therapy
were	VBD	be
stronger	JJR	strong
in	IN	in
males	NNS	male
and	CC	and
in	IN	in
individuals	NNS	individual
with	IN	with
higher	JJR	high
baseline	NN	baseline
FLI	NNP	FLI
,	,	,
higher	JJR	high
GOT	NNP	Got
,	,	,
and	CC	and
higher	JJR	high
cholesterol	NN	cholesterol
levels	NNS	level
.	.	.
</s>
<s type="decl">
Each	DT	each
additional	JJ	additional
fasting	NN	fasting
day	NN	day
further	RBR	far
decreased	VBD	decrease
the	DT	the
FLI	NNP	FLI
.	.	.
</s>
<s type="decl">
The	DT	the
binary	JJ	binary
logistic	JJ	logistic
regression	NN	regression
showed	VBD	show
that	IN	that
every	DT	every
day	NN	day
of	IN	of
fasting	NN	fasting
increase	NN	increase
by	IN	by
40	CD	40
%	NN	%
the	DT	the
chance	NN	chance
to	TO	to
improve	VB	improve
a	DT	a
manifest	JJ	manife
fatty	NN	fatty
liver	NN	liver
(	-LRB-	(
FLI	NNP	FLI
&gt;	SYM	&gt;
60	CD	60
)	-RRB-	)
and	CC	and
switch	VB	switch
to	IN	to
a	DT	a
lower	JJR	low
category	NN	category
of	IN	of
risk	NN	risk
.	.	.
</s>
<s type="decl">
This	DT	this
implies	VBZ	imply
that	IN	that
the	DT	the
duration	NN	duration
of	IN	of
fasting	NN	fasting
must	MD	must
be	VB	be
sufficient	JJ	sufficient
to	TO	to
influence	VB	influence
fatty	JJ	fatty
liver	NN	liver
positively	RB	positively
.	.	.
</s>
<s type="sub">
This	DT	this
should	MD	should
be	VB	be
taken	VBN	take
into	IN	into
account	NN	account
when	WRB	when
periodic	JJ	periodic
fasting	NN	fasting
is	VBZ	be
considered	VBN	consider
as	IN	as
treatment	NN	treatment
for	IN	for
NAFLD	NNP	NAFLD
.	.	.
</s>
</p>
<p>
<s type="decl">
As	IN	as
already	RB	already
mentioned	VBN	mention
,	,	,
insulin	NN	insulin
resistance	NN	resistance
,	,	,
T2DM	NN	T2DM
,	,	,
and	CC	and
the	DT	the
development	NN	development
of	IN	of
NAFLD	NNP	NAFLD
are	VBP	be
closely	RB	closely
associated	VBN	associate
conditions	NNS	condition
.	.	.
</s>
<s type="decl">
Taylor	NNP	Taylor
et	FW	et
al.	NNS	al.
have	VBP	have
shown	VBN	show
that	IN	that
remission	NN	remission
of	IN	of
T2DM	NN	T2DM
requires	VBZ	require
a	DT	a
decrease	NN	decrease
of	IN	of
liver	NN	liver
fat	NN	fat
.	.	.
</s>
<s type="decl">
Patients	NNS	patient
with	IN	with
T2DM	NNP	T2DM
tend	VBP	tend
to	TO	to
have	VB	have
higher	JJR	high
FLI	NNP	FLI
scores	NNS	score
,	,	,
but	CC	but
in	IN	in
this	DT	this
study	NN	study
,	,	,
we	PRP	we
could	MD	could
demonstrate	VB	demonstrate
that	IN	that
the	DT	the
fasting	NN	fasting
intervention	NN	intervention
was	VBD	be
equally	RB	equally
effective	JJ	effective
in	IN	in
T2DM	NN	T2DM
patients	NNS	patient
and	CC	and
in	IN	in
non-diabetic	JJ	non-diabetic
subjects	NNS	subject
in	IN	in
terms	NNS	term
of	IN	of
FLI	NNP	FLI
,	,	,
although	IN	although
the	DT	the
improvement	NN	improvement
of	IN	of
other	JJ	other
parameters	NNS	parameter
(	-LRB-	(
e.g.	FW	e.g.
,	,	,
HDL	NNP	HDL
,	,	,
LDL	NNP	LDL
,	,	,
and	CC	and
AP	NNP	AP
)	-RRB-	)
was	VBD	be
not	RB	not
as	RB	as
complete	JJ	complete
.	.	.
</s>
<s type="decl">
These	DT	this
results	NNS	result
are	VBP	be
in	IN	in
line	NN	line
with	IN	with
a	DT	a
previous	JJ	previous
study	NN	study
on	IN	on
periodic	JJ	periodic
fasting	NN	fasting
in	IN	in
T2DM	NNP	T2DM
.	.	.
</s>
</p>
<p>
<s type="decl">
Liver	NN	liver
enzymes	NNS	enzyme
,	,	,
insulin	NN	insulin
resistance	NN	resistance
,	,	,
and	CC	and
cholesterol	NN	cholesterol
levels	NNS	level
are	VBP	be
related	VBN	relate
in	IN	in
NAFLD	NNP	NAFLD
.	.	.
</s>
<s type="decl">
Our	PRP$	our
results	NNS	result
supported	VBD	support
a	DT	a
correlation	NN	correlation
between	IN	between
changes	NNS	change
in	IN	in
FLI	NNP	FLI
and	CC	and
changes	NNS	change
in	IN	in
liver	NN	liver
enzymes	NNS	enzyme
(	-LRB-	(
GGT	NNP	GGT
,	,	,
and	CC	and
GOT	NNP	Got
)	-RRB-	)
and	CC	and
lipid	NN	lipid
parameters	NNS	parameter
(	-LRB-	(
TG	CD	TG
)	-RRB-	)
after	IN	after
fasting	NN	fasting
intervention	NN	intervention
,	,	,
although	IN	although
this	DT	this
was	VBD	be
limited	VBN	limit
to	IN	to
subjects	NNS	subject
without	IN	without
T2DM	NNP	T2DM
.	.	.
</s>
</p>
</text>